Digital Bioprocessing Technologies to Boost Drug Makers’ Product Quality and Reduce Costs, Says Expert
According to industry expert Karlheinz Landauer, digital bioprocessing technologies have the potential to greatly improve drug makers’ product quality, while simultaneously reducing manufacturing costs. Landauer notes that the combination of quality-by-design (QbD) and digital technologies offers numerous advantages to the drug industry.
Exclusive Access: Unlock Premium, Confidential Insights
Unlock This Exclusive Content—Subscribe Instantly!
Login if you have purchased
